Context Therapeutics
CNTX
CNTX
42 hedge funds and large institutions have $95.8M invested in Context Therapeutics in 2025 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
5.92% less ownership
Funds ownership: 76.88% → 70.96% (-5.9%)
Holders
42
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.04M | |
| 2 | +$2.99M | |
| 3 | +$340K | |
| 4 |
Renaissance Technologies
New York
|
+$220K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$106K |
Top Sellers
| 1 | -$4.7M | |
| 2 | -$4.06M | |
| 3 | -$1.9M | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
-$390K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$80.6K |
